Physician profile
Preeth Sundaran
NPI 1043523186
$602.42
in general payments reported to CMS, 2019-2025
8 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.19 · 2022: $137 · 2023: $223 · 2024: $43.04 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $182.39 | 2022-2024 | Linq II |
| Cvrx, INC. | $93.07 | 2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.15 | 2022-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $76.58 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $67.30 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $51.01 | 2025 | Eliquis, Camzyos |
| Regeneron Healthcare Solutions, INC. | $28.84 | 2025 | Dupixent |
| Lantheus Medical Imaging, INC. | $22.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preeth Sundaran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.